JNCCN-360

Editor:

James L. Mohler, MD

Advertisement

Advertisement

Howard I. Scher, MD, on Managing Enzalutamide Toxicities in Prostate Cancer

Sumit K. Subudhi, MD, PhD, on Monitoring the Progress of Prostate Cancer Treated With Apalutamide

Sumit K. Subudhi, MD, PhD, on Managing Apalutamide Toxicities in Prostate Cancer

Recent

AACR 2019: Abiraterone Acetate and Preexisting Cardiovascular Disease in Patients With Prostate Cancer

Targeting Fatty Acid Transporter to Prevent Disease Progression in Prostate Cancer

2019 ASCO-SITC: Genetic Characterization of BRCA-Mutant Prostate Cancer

2019 GU Symposium: Survival May Vary by Race in Some Patients Treated for Prostate Cancer

Published

Medical Literature

Lipid-Lowering Medication and Risk of Prostate Cancer

Active Surveillance vs. Radical Treatment of Prostate Cancer

Impact of Race on Survival in Metastatic Castration-Resistant Prostate Cancer

Androgen-Deprivation Therapy for Prostate Cancer: Managing Cardiovascular Risks

Ongoing

Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers

New Directions in Nonmetastatic CRPC: Perspectives on the Latest Data (login required)

Metastatic CRPC: Clinical Strategies (login required)

Prostate Cancer Patient Management Simulator

Available

Clinical Trials

MD Anderson Cancer Center

Moffitt Cancer Center

University of Nebraska

Dana-Farber Cancer Institute

Sections

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.